Annual Drug Patent Expirations for HETLIOZ+LQ Hetlioz Lq is a drug marketed by Vanda Pharms Inc and is included in one NDA. It is available from one supplier. There are…
Source
Annual Drug Patent Expirations for TALICIA Talicia is a drug marketed by Redhill and is included in one NDA. It is available from one supplier. There are five patents protecting…
Source
Annual Drug Patent Expirations for BRUKINSA Brukinsa is a drug marketed by Beigene and is included in one NDA. It is available from one supplier. There are seven patents protecting…
Source
Annual Drug Patent Expirations for HETLIOZ Hetlioz is a drug marketed by Vanda Pharms Inc and is included in two NDAs. It is available from one supplier. There are twenty-seven…
Source
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Netherlands. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
Source
Which pharmaceutical companies have the most SPCs in Netherlands? Read Post »
Annual Drug Patent Expirations for SKYCLARYS Skyclarys is a drug marketed by Reata Pharms and is included in one NDA. It is available from one supplier. There are six patents…
Source
Annual Drug Patent Expirations for LODOCO Lodoco is a drug marketed by Agepha Pharma Fz and is included in one NDA. It is available from one supplier. There are eight…
Source
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit www.DrugPatentWatch.com
Source
New tentative approval for MYLAN drug efavirenz, emtricitabine and tenofovir alafenamide Read Post »
This chart shows which pharmaceutical companies received the most new drug approvals last year. The drug companies with the most new drugs last year are Baxter Hlthcare Corp Pfizer Exela…
Source
Pharmaceutical companies with the most drug approvals last year Read Post »
EXSERVAN (riluzole) Aquestive Patent: 8,603,514 Expiration: Apr 3, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
Source
Drug Patent Expirations for the Week of March 31, 2024 Read Post »
Get new actionable insights and updates from BiotechBlog
